Literature DB >> 33950797

Preference of influenza vaccination among the elderly population in Shaanxi province, China.

Minghuan Jiang1,2,3,4, Pengchao Li1,2,3,4, Xuelin Yao1,2,3,4, Khezar Hayat1,2,3,4,5, Yilin Gong1,2,3,4, Shan Zhu1,2,3,4, Jin Peng1,2,3,4, Xinke Shi6, Zhaojing Pu6, Yifan Huang6, Yu Fang1,2,3,4.   

Abstract

The influenza vaccination uptake rate is low in China. In the current study, we aimed to explore the preferences of influenza vaccination among the Chinese elderly. A discrete choice experiment design was performed to assess their preferences toward five influenza vaccination attributes, including vaccine effectiveness, duration of protection, severe adverse effects, vaccination cost, and vaccination recommendation source. A total of 144 participants aged over 60 years from three cities of Shaanxi province in China were surveyed. A mixed logit model was employed to analyze the data. The elderly population were found to prefer influenza vaccination with a longer duration of protection, followed by lower severe adverse effects, higher vaccine effectiveness, and recommended by healthcare providers. The vaccination cost was the least important attribute. The most considerable marginal willingness to pay for vaccination (CNY220.90) and the highest vaccination choice probability (83.70%) occurred when the duration of protection extended from 3 to 12 months. The present study's findings would inform decision-makers on implementing appropriate interventions for the increase of influenza vaccination coverage among the elderly in China.

Entities:  

Keywords:  Discrete choice experiment; elderly; influenza vaccination; preference; willingness to pay

Mesh:

Substances:

Year:  2021        PMID: 33950797      PMCID: PMC8381797          DOI: 10.1080/21645515.2021.1913029

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  28 in total

1.  Deriving welfare measures from discrete choice experiments: inconsistency between current methods and random utility and welfare theory.

Authors:  Emily Lancsar; Elizabeth Savage
Journal:  Health Econ       Date:  2004-09       Impact factor: 3.046

2.  The free vaccination policy of influenza in Beijing, China: The vaccine coverage and its associated factors.

Authors:  Min Lv; Renfei Fang; Jiang Wu; Xinghuo Pang; Ying Deng; Trudy Lei; Zheng Xie
Journal:  Vaccine       Date:  2016-02-23       Impact factor: 3.641

3.  Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Authors:  John F P Bridges; A Brett Hauber; Deborah Marshall; Andrew Lloyd; Lisa A Prosser; Dean A Regier; F Reed Johnson; Josephine Mauskopf
Journal:  Value Health       Date:  2011-04-22       Impact factor: 5.725

4.  Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies.

Authors:  Barnaby Young; Sapna Sadarangani; Lili Jiang; Annelies Wilder-Smith; Mark I-Cheng Chen
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

5.  Mothers' Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong.

Authors:  Carlos K H Wong; Kenneth K C Man; Patrick Ip; Mike Kwan; Sarah M McGhee
Journal:  Value Health       Date:  2017-11-15       Impact factor: 5.725

6.  Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccine.

Authors:  Joseph Arbiol; Mitsuyasu Yabe; Hisako Nomura; Maridel Borja; Nina Gloriani; Shin-ichi Yoshida
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Practice-proven interventions to increase vaccination rates and broaden the immunization season.

Authors:  Patricia K Stinchfield
Journal:  Am J Med       Date:  2008-07       Impact factor: 4.965

8.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

9.  Parents' preferences and willingness-to-pay for human papilloma virus vaccines in Thailand.

Authors:  Surachat Ngorsuraches; Kornwan Nawanukool; Krittin Petcharamanee; Ungkanit Poopantrakool
Journal:  J Pharm Policy Pract       Date:  2015-07-22

10.  Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12).

Authors:  Lei Zhou; Qiru Su; Zhen Xu; Ao Feng; Hui Jin; Shiyuan Wang; Zijian Feng
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  1 in total

1.  Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study.

Authors:  Renfeng Fan; Xiaoyuan Huang; Xuanxuan Nian; Zhiqiang Ou; Jian Zhou; Jiayou Zhang; Peiyu Zeng; Wei Zhao; Jinglong Deng; Wei Chen; Shaomin Chen; Kai Duan; Yingshi Chen; Xinguo Li; Jikai Zhang; Xiaoming Yang
Journal:  Hum Vaccin Immunother       Date:  2021-09-02       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.